ACBD3 and hepatocellular carcinoma: With respect to our data, it is obvious that up-regulation of hMT3 results in the protection of HCC cells against the accumulation of lipids and induction of ferroptosis through negative regulation of expression FDFT1, ACSF2 and ACBD3, which is an obvious and important factor affecting resistance of HCC cells to sorafenib.